On Feb 26, 2018, Delmarva Foundation, Health Integrity, Quality Health Foundation, and Quality Health Strategies came together under a new name: Qlarant. Some of the content below was created prior to this change and may contain our old name(s). Learn More
The Centers for Medicare & Medicaid Services selected Qlarant as a Prime awardee of the Network of Quality Improvement and Innovation Contractors. This designation will allow NQIICs to bid on Task Orders over the next five years
Qlarant Foundation, the mission arm of Qlarant, recently awarded grants totaling $384,000 to 18 organizations in Maryland and Washington, DC supporting local healthcare-related quality improvement efforts.
Qlarant CEO, Ron Forsythe, was part of a group that rang the bell to begin trading on the New York Stock Exchange the morning of May 20th, 2019.
Qlarant has been selected by The Silicon Review, as one of the top 10 fastest growing data analytics companies for 2019.
Qlarant Sr. Pharmacist, Jennifer Thomas, PharmD, has been selected by ImmunizeDC, a community group dedicated to promoting complete vaccine protection, to Chair their Special Projects Committee.